ABVC BioPharma, Inc. (ABVC)
0.8444
-0.08
(-8.22%)
USD |
NASDAQ |
Aug 24, 16:00
0.8444
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Net Income (Quarterly) : -0.8105M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8105M |
| March 31, 2026 | -1.690M |
| December 31, 2025 | -3.016M |
| September 30, 2025 | -2.084M |
| June 30, 2025 | -2.333M |
| March 31, 2025 | -0.9442M |
| December 31, 2024 | 0.1289M |
| September 30, 2024 | -0.4874M |
| June 30, 2024 | -1.047M |
| March 31, 2024 | -2.928M |
| December 31, 2023 | -3.330M |
| September 30, 2023 | -3.368M |
| June 30, 2023 | -2.315M |
| March 31, 2023 | -1.897M |
| December 31, 2022 | -4.501M |
| September 30, 2022 | -3.776M |
| June 30, 2022 | -1.947M |
| March 31, 2022 | -6.088M |
| September 30, 2021 | -1.886M |
| June 30, 2021 | -2.053M |
| March 31, 2021 | -1.195M |
| December 31, 2020 | -4.969M |
| September 30, 2020 | -2.131M |
| June 30, 2020 | -2.184M |
| March 31, 2020 | -1.309M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.116M |
| September 30, 2019 | -1.330M |
| June 30, 2019 | -0.6145M |
| March 31, 2019 | -0.8733M |
| December 31, 2018 | -3.928M |
| September 30, 2018 | -0.6873M |
| June 30, 2018 | -0.736M |
| March 31, 2018 | -0.7136M |
| December 31, 2017 | -0.3812M |
| September 30, 2017 | -3.862M |
| June 30, 2017 | -0.2179M |
| December 31, 2016 | -0.2103M |
| September 30, 2016 | -10.65M |
| June 30, 2016 | -0.2932M |
| March 31, 2016 | -6.609M |
| December 31, 2015 | -3.501M |
| September 30, 2015 | -0.0309M |
| June 30, 2015 | -0.0015M |
| March 31, 2015 | 0.0011M |
| December 31, 2014 | -0.001M |
| September 30, 2014 | -0.024M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -14.84M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.7369M |
| EPS Diluted (Quarterly) | -0.0283 |
| Enterprise Value | 28.48M |
| Earnings Yield | -34.08% |
| Normalized Earnings Yield | -31.43 |